Veillonellaceae: The Lactate-Feeding Family of Oral-Gut Connectivity and Metabolic Modulation

The family Veillonellaceae represents a distinctive group of Gram-negative anaerobic cocci that occupy a unique ecological niche at the intersection of oral and gut microbial communities. Unlike most other bacterial families that specialize in degrading complex polysaccharides, Veillonellaceae are lactate fermenters, thriving on the metabolic waste products of other bacteria. This unusual metabolic strategy positions them as keystone organisms in microbial cross-feeding networks, converting lactic acid into short-chain fatty acids that shape the chemical environment of the oral cavity and gastrointestinal tract.

Members of the Veillonellaceae family include the genera Veillonella, Megasphaera, Dialister, and others, with Veillonella being the most prominent and extensively studied. These bacteria are characterized by their strict anaerobic metabolism, their inability to ferment carbohydrates directly, and their absolute requirement for lactate or other organic acids as energy sources. Their metabolic activity generates propionate, acetate, and other short-chain fatty acids that influence local pH, modulate immune responses, and serve as energy substrates for host tissues.

Recent research from 2024 through 2026 has dramatically transformed our understanding of this family's clinical significance. The discovery that Veillonella species can improve athletic performance by converting lactate to propionate has positioned them as potential next-generation probiotics for endurance athletes. Concurrently, groundbreaking studies have revealed that Veillonella and other family members play a critical role in oral–gut translocation, moving from the mouth to the gut where they contribute to the pathogenesis of advanced chronic liver disease through a collagenase enzyme encoded by the prtC gene. This dual nature, with beneficial effects in some contexts and pathogenic roles in others, mirrors the complexity seen in other microbial families and underscores the importance of context in host-microbe interactions. The family's central position in oral ecology and its emerging role in systemic disease highlight the profound connections between oral health, gut health, and overall physiological function.

---

Where It Is Found

Veillonellaceae bacteria are found throughout the human body, with highest abundance in the oral cavity and the gastrointestinal tract.

Oral Cavity Distribution

The oral cavity is the primary habitat for Veillonellaceae, where they are among the most abundant and prevalent bacterial species.

· Dental Plaque: Veillonella species are early colonizers of dental plaque, forming part of the initial biofilm on tooth surfaces. They adhere to other bacteria rather than directly to the tooth surface, establishing complex multispecies communities.

· Tongue Surface: The dorsal surface of the tongue harbors high concentrations of Veillonella, where they participate in the complex microbial communities responsible for oral malodor in some individuals.

· Saliva: Veillonella species are consistently detected in saliva, with their abundance serving as a marker of oral health status. Higher relative abundance correlates with periodontal disease and poor oral hygiene.

· Subgingival Pockets: In periodontitis, Veillonella species become more abundant in the subgingival environment, where they associate with red-complex pathogens.

Gastrointestinal Distribution

Veillonellaceae colonize the entire gastrointestinal tract, though their abundance varies along its length.

· Stomach: Low numbers survive gastric transit, with some species adapted to the acidic environment.

· Small Intestine: Moderate abundance in the jejunum and ileum, where lactate from dietary sources and other bacteria is available.

· Large Intestine: Highest abundance in the colon, where they participate in cross-feeding networks with lactate-producing bacteria.

· Fecal Microbiome: Veillonella species are regularly detected in fecal samples, though at lower relative abundance than in the oral cavity.

Body Sites Beyond the Oral and Gastrointestinal Tracts

· Respiratory Tract: Veillonella can be detected in the upper respiratory tract and, in some conditions, in the lower airways.

· Female Genital Tract: Some Veillonella species are present in the vaginal microbiome, though typically at low abundance.

· Bloodstream: Under conditions of barrier disruption, particularly in advanced chronic liver disease, Veillonella can translocate to the bloodstream.

Animal Reservoirs

Veillonellaceae are found in the gastrointestinal tracts of various mammals, including ruminants, pigs, and rodents. The genus Megasphaera, a member of this family, is particularly abundant in the rumen of cattle and sheep, where it plays a critical role in preventing lactic acidosis by fermenting excess lactate produced by other rumen bacteria.

Factors Affecting Abundance

· Lactate Availability: As lactate fermenters, Veillonellaceae abundance is directly tied to the availability of lactate from other bacteria or dietary sources.

· Oral Health Status: Periodontal disease and poor oral hygiene are associated with increased Veillonella abundance in the oral cavity.

· Diet: Diets rich in fermentable carbohydrates promote lactate-producing bacteria, which in turn support Veillonellaceae growth.

· Nitrate Intake: Dietary nitrate from vegetables can be reduced to nitrite by oral bacteria, and Veillonella can utilize nitrate as an electron acceptor, enhancing their growth in lactate-deficient environments.

· Chronic Liver Disease: Advanced chronic liver disease is associated with increased oral–gut translocation and elevated Veillonella abundance in the gut.

· Antibiotic Exposure: Broad-spectrum antibiotics, particularly those with anaerobic activity, deplete Veillonellaceae populations.

---

1. Taxonomic Insights

Family Name: Veillonellaceae Rogosa 1971

Phylum: Bacillota (formerly Firmicutes)

Class: Negativicutes

Order: Veillonellales

Taxonomic Note

The family Veillonellaceae occupies a unique position within the Bacillota phylum, as its members are Gram-negative despite belonging to a phylum otherwise dominated by Gram-positive bacteria. This unusual characteristic reflects a secondary loss of the thick Gram-positive cell wall. The family was established in 1971 to accommodate the genus Veillonella and related organisms. Recent taxonomic revisions published in 2025 have refined the family's classification, with the family now comprising four validly published genera: Veillonella, Megasphaera, Dialister, and Negativicoccus.

Key Genera

· Veillonella: The type genus and most extensively studied member, encompassing over a dozen species isolated from human and animal habitats. V. parvula, V. atypica, and V. dispar are the most common human-associated species.

· Megasphaera: A genus of larger cocci that, like Veillonella, ferments lactate to short-chain fatty acids. M. elsdenii is well-known from the rumen, and novel species such as M. jansseni continue to be described.

· Dialister: A genus of small, Gram-negative anaerobic cocci found in the oral cavity, gut, and other body sites. Some species are associated with various infections.

· Negativicoccus: A recently described genus within the family, with species isolated from human clinical specimens.

Major Veillonella Species and Their Habitats

Veillonella parvula (Veillonellaceae)

The most extensively studied and widely distributed Veillonella species. It is a common member of the oral microbiota and a frequent isolate from the gut. Recent research has identified V. parvula as a key translocating species in advanced chronic liver disease, where it contributes to gut barrier impairment and hepatic fibrosis through its collagenase activity.

Veillonella atypica (Veillonellaceae)

A species closely related to V. parvula, commonly found in the oral cavity and gut. V. atypica has gained attention for its potential role in athletic performance, with studies showing increased abundance in marathon runners post-race. In vitro characterization has demonstrated promising probiotic properties, including tolerance to simulated gastrointestinal conditions and absence of virulence factors.

Veillonella dispar (Veillonellaceae)

A common oral and gut species with distinctive metabolic capabilities. Research published in 2024 demonstrated that nitrate promotes V. dispar growth in lactate-deficient environments by facilitating the catabolism of glutamate and aspartate, producing short-chain fatty acids and tryptophan.

Veillonella denticariosi (Veillonellaceae)

A species associated with dental caries, though its precise role in caries pathogenesis remains under investigation.

Genomic Insights

The genomes of Veillonellaceae members reflect their specialized metabolic niche and their adaptation to host environments.

· Genome Size: Typically ranging from 1.8 to 2.4 Mbp, smaller than many other gut bacteria, reflecting their specialized metabolic capabilities.

· GC Content: Low GC content of approximately 38-42%, characteristic of the Negativicutes class.

· Lactate Metabolism: Central to the Veillonellaceae genome is the lactate dehydrogenase pathway, enabling conversion of lactate to pyruvate and subsequently to propionate and acetate via the methylmalonyl-CoA pathway.

· Nitrate Reduction: Many Veillonella species possess the narGHJI operon encoding nitrate reductase, allowing them to utilize nitrate as an electron acceptor for anaerobic respiration, conferring a competitive advantage in nitrate-rich environments.

· Collagenase Gene (prtC): Recent genomic analyses have identified the prtC gene encoding a collagenase-like proteinase in translocating Veillonella strains. This gene is associated with gut barrier impairment and disease pathogenesis.

· Mobile Genetic Elements: Veillonellaceae genomes contain various mobile genetic elements that facilitate horizontal gene transfer, contributing to their adaptability and, in some contexts, their pathogenic potential.

Family Characteristics

Veillonellaceae share several defining features that distinguish them from other bacterial families.

· Gram-negative cell wall structure despite belonging to the Gram-positive phylum Bacillota.

· Strictly anaerobic metabolism, though some species show limited oxygen tolerance.

· Unable to ferment carbohydrates directly; require lactate, pyruvate, or other organic acids as energy sources.

· Produce propionate, acetate, and other short-chain fatty acids as major fermentation end products.

· Coccoid or, in the case of Megasphaera, slightly elongated cellular morphology.

· Typically non-motile and non-spore-forming.

· Commonly found in association with lactate-producing bacteria, forming metabolic consortia.

---

2. Therapeutic Actions

Primary Actions

· Lactate fermenter (converts lactate to short-chain fatty acids)

· Short-chain fatty acid producer (propionate, acetate)

· Metabolic regulator (propionate effects on energy metabolism)

· Athletic performance enhancer (via lactate removal and propionate production)

· Oral biofilm participant (early colonizer in dental plaque)

Secondary Actions

· Immune modulator (via SCFAs)

· Nitrate reducer (contributing to nitric oxide production)

· Anti-inflammatory (context-dependent)

· Oral-gut translocation marker (indicator of barrier dysfunction)

· Collagenase producer (pathogenic in certain contexts)

---

3. Bioactive Components and Their Action

Lactate Metabolism and Propionate Production

The central metabolic activity of Veillonellaceae is the fermentation of lactate to propionate and acetate, a process with profound implications for host health.

· Lactate Conversion: Veillonella species take up lactate produced by other bacteria, including streptococci and lactobacilli, and convert it to pyruvate via lactate dehydrogenase. Pyruvate is then metabolized to propionate via the methylmalonyl-CoA pathway.

· Propionate as a Signaling Molecule: Propionate produced by Veillonellaceae activates G-protein coupled receptors (GPR41 and GPR43) on enteroendocrine cells, influencing hormone secretion including glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). These hormones regulate appetite, insulin secretion, and gut motility.

· Energy Substrate for Host: Propionate is transported to the liver where it serves as a substrate for gluconeogenesis, contributing to glucose homeostasis.

· Athletic Performance: In high-performance athletes, Veillonella abundance increases post-exercise, and propionate production is believed to contribute to enhanced endurance and recovery.

Short-Chain Fatty Acids (SCFAs)

Beyond propionate, Veillonellaceae produce other SCFAs with distinct biological activities.

· Acetate: Produced alongside propionate, acetate serves as an energy substrate for colonocytes and a substrate for butyrate production by other gut bacteria.

· Butyrate: Some Megasphaera species produce butyrate directly, contributing to the pool of this critical colonocyte fuel.

· Branched-Chain Fatty Acids: Minor fermentation products that may have signaling functions in the gut.

Nitrate Reduction and Nitric Oxide Production

Veillonellaceae possess the capacity to reduce nitrate, a function with important implications for host health.

· Nitrate to Nitrite: Veillonella species express nitrate reductase (narGHJI operon), converting dietary nitrate to nitrite.

· Nitric Oxide Generation: Nitrite can be further reduced to nitric oxide, a critical signaling molecule that regulates blood pressure, immune function, and gastrointestinal motility.

· Competitive Advantage: Nitrate respiration provides a competitive advantage in environments where lactate is limiting, as demonstrated in studies showing nitrate promotes V. dispar growth on amino acids.

· Cardiovascular Health: The nitrate-nitrite-nitric oxide pathway is linked to beneficial cardiovascular effects, including blood pressure reduction and improved endothelial function.

Amino Acid Metabolism

Recent research has revealed that Veillonellaceae can utilize amino acids as alternative carbon sources when lactate is unavailable.

· Glutamate and Aspartate Catabolism: In lactate-deficient environments, nitrate promotes the catabolism of glutamate and aspartate by V. dispar, generating short-chain fatty acids and tryptophan.

· Tryptophan Production: The conversion of aspartate to tryptophan is notable, as tryptophan is a precursor for serotonin and other bioactive molecules.

· Metabolic Flexibility: This ability to switch between carbon sources enables Veillonellaceae to survive in diverse host environments with fluctuating nutrient availability.

Collagenase (PrtC)

A recently discovered virulence factor with significant pathogenic implications.

· Enzymatic Activity: The prtC gene encodes a collagenase-like proteinase that degrades type I collagen, a key component of the gut barrier and extracellular matrix.

· Gut Barrier Disruption: Collagenase activity weakens the intestinal barrier, increasing permeability and facilitating translocation of bacteria and bacterial products into the circulation.

· Disease Association: PrtC is uniquely shared by oral–gut translocating bacteria in advanced chronic liver disease, and its fecal abundance serves as a robust biomarker for disease severity.

Surface Structures and Immune Interactions

Like all Gram-negative bacteria, Veillonellaceae possess lipopolysaccharide (LPS) in their outer membranes.

· LPS Structure: Veillonella LPS has distinct structural features compared to enterobacterial LPS, with differences in lipid A composition that may influence immunostimulatory properties.

· Biofilm Formation: Veillonella species participate in multispecies biofilms, particularly in the oral cavity, where they adhere to other bacteria rather than directly to surfaces.

· Adhesins: Surface proteins mediate adherence to other bacteria, enabling Veillonella to serve as a bridging species in oral biofilm development.

---

4. Clinical and Therapeutic Applications

Periodontal Disease

Veillonellaceae play a complex role in periodontal health and disease, with associations that shift depending on the context of the microbial community.

· Association with Disease: Multiple studies have demonstrated that increased Veillonella abundance in saliva and subgingival plaque is associated with periodontal disease. Veillonella species, particularly V. parvula, are frequently isolated from periodontal pockets.

· Bridging Species: In dental plaque ecology, Veillonella serves as a bridging species, connecting early colonizers like streptococci with later colonizers including periodontopathogens such as Porphyromonas gingivalis.

· Inflammophilic Character: Veillonella may benefit from the inflammatory environment of periodontitis, a concept termed "inflammophilic" in which certain bacteria thrive in inflamed tissues.

· Protective Role: Some evidence suggests Veillonella may have protective effects in certain contexts, potentially through competition with more pathogenic species or through production of antimicrobial compounds.

Advanced Chronic Liver Disease (ACLD)

The most significant clinical development in Veillonellaceae research is the elucidation of their role in ACLD pathogenesis.

· Oral–Gut Translocation: In patients with ACLD, Veillonella and Streptococcus species translocate from the oral cavity to the gut, establishing ectopic populations. This translocation increases with disease severity and is not observed in hospitalized patients without liver disease.

· Collagenase as a Pathogenic Mechanism: Translocating Veillonella strains carry the prtC gene encoding a collagenase that degrades gut barrier collagen. This weakens intestinal integrity, allowing bacterial products to enter the portal circulation and reach the liver.

· Exacerbation of Fibrosis: In a mouse model of hepatic fibrosis, inoculation with Veillonella and Streptococcus isolates from ACLD patients exacerbated gut barrier impairment, increased hepatic and intestinal fibrosis, and promoted small-intestinal bacterial overgrowth.

· Diagnostic Biomarker: Fecal abundance of the prtC gene distinguishes ACLD patients from healthy individuals with accuracy comparable to clinical diagnostic tools (area under precision-recall curve = 0.91). This offers potential for early diagnosis of liver disease progression.

· Therapeutic Target: PrtC represents a potential therapeutic target for preventing or treating ACLD, with implications for developing inhibitors of collagenase activity or strategies to prevent oral–gut translocation.

Athletic Performance and the Gut-Muscle Axis

The association between Veillonella and athletic performance has emerged as one of the most exciting areas of microbiome research.

· Post-Exercise Enrichment: Studies of marathon runners have shown increased abundance of Veillonella atypica in fecal samples collected post-race, particularly in athletes with high performance levels.

· Lactate Utilization: During intense exercise, lactate accumulates in the bloodstream and is released into the gut. Veillonella can utilize this lactate, converting it to propionate, which may serve as an energy substrate.

· Animal Model Evidence: Mice administered Veillonella atypica showed a 13% improvement in running time compared to control animals, supporting a causal relationship between Veillonella colonization and enhanced endurance.

· Probiotic Potential: Veillonella atypica ATCC 17744 has been characterized for safety and functional properties, showing tolerance to simulated gastrointestinal conditions, absence of virulence factors, and sensitivity to antibiotics. This positions it as a candidate for functional food formulations targeting athletes.

· Systematic Review Support: Recent systematic reviews confirm that probiotic supplementation can enhance physical performance, attenuate fatigue, and accelerate recovery, with Veillonella representing a promising strain for this application.

Inflammatory Bowel Disease

The role of Veillonellaceae in inflammatory bowel disease (IBD) is complex and context-dependent.

· Increased Abundance: Some studies report increased Veillonella abundance in IBD patients, particularly in ulcerative colitis.

· Translocation Phenomena: As in ACLD, oral–gut translocation of Veillonella has been observed in IBD, suggesting that barrier dysfunction may enable oral bacteria to colonize the gut.

· Thiopurine Metabolism: Veillonella parvula can degrade immunosuppressive thiopurine drugs, potentially impacting therapeutic efficacy in IBD patients.

· Collagenase Contribution: The collagenase activity of some Veillonella strains may contribute to gut barrier impairment in IBD, similar to its role in ACLD.

Rheumatoid Arthritis and Other Autoimmune Conditions

Oral–gut translocation of Veillonella has been implicated in various autoimmune and inflammatory conditions.

· Rheumatoid Arthritis: Oral bacteria, including Veillonella, have been detected in the gut of rheumatoid arthritis patients, with potential roles in disease pathogenesis.

· Type 1 Diabetes: Similar translocation patterns have been observed, suggesting a broader phenomenon across autoimmune diseases.

· Hypertension: Veillonella abundance is altered in hypertension, with potential links through the nitrate-nitric oxide pathway.

Systemic Infections

While primarily commensal, Veillonellaceae can cause opportunistic infections under certain conditions.

· Bacteremia: Veillonella species are occasionally isolated from blood cultures, particularly in immunocompromised patients or those with underlying gastrointestinal disease.

· Endocarditis: Rare cases of Veillonella endocarditis have been reported, typically in patients with underlying valvular disease.

· Deep-Seated Infections: Veillonella can be isolated from abscesses and other deep-seated infections, often in polymicrobial contexts.

Oral Health Beyond Periodontitis

Veillonellaceae influence various aspects of oral health beyond periodontitis.

· Dental Caries: Veillonella species are detected in caries lesions, though their role in caries pathogenesis is less established than acidogenic bacteria.

· Halitosis: Veillonella can produce volatile sulfur compounds that contribute to oral malodor, particularly in individuals with periodontal disease.

· Oral Biofilm Ecology: As early colonizers, Veillonella play a critical role in establishing dental plaque communities, interacting metabolically with initial, middle, and late colonizers.

---

5. Therapeutic Preparations and Formulations

Live Biotherapeutic Products

Purpose: For athletic performance enhancement, metabolic health, and conditions benefiting from enhanced propionate production.

· Strain Selection: Veillonella atypica ATCC 17744 is the leading candidate for probiotic development, based on:

· Association with improved athletic performance

· In vitro characterization showing tolerance to gastrointestinal stress

· Absence of hemolytic activity or virulence factors

· Sensitivity to all tested antibiotics

· Moderate hydrophobicity and auto-aggregation properties

· Cultivation Requirements: Veillonellaceae are strictly anaerobic bacteria requiring specialized culture conditions. They grow well on media containing lactate and may require hemin for optimal growth.

· Safety Considerations: Comprehensive safety characterization is required, including assessment of antibiotic resistance profiles, hemolytic activity, and potential for collagenase production.

· Regulatory Status: Veillonella-based products are investigational and not currently approved for medical use. Their classification as probiotics or live biotherapeutics will depend on intended use and health claims.

Synbiotic Formulations

Purpose: To enhance Veillonella growth and activity through targeted prebiotic substrates.

· Lactate-Containing Formulations: As lactate is the primary energy source for Veillonella, formulations containing lactate or promoting lactate production could support their growth.

· Nitrate Supplementation: Dietary nitrate enhances Veillonella growth in lactate-deficient environments, making nitrate-containing foods (beets, leafy greens) potential synbiotic partners.

· Amino Acid Combinations: Glutamate and aspartate can serve as alternative carbon sources, supporting Veillonella in diverse nutritional contexts.

Functional Foods for Athletes

Purpose: To support endurance and recovery through Veillonella supplementation.

· Post-Exercise Formulations: Products designed for consumption after exercise could capitalize on elevated lactate levels in the gut, supporting Veillonella colonization.

· Combination Products: Combining Veillonella with lactate-producing bacteria (e.g., Streptococcus salivarius) could create self-sustaining consortia.

· Delivery Systems: Protection from gastric acidity and targeted delivery to the small intestine and colon will be critical for effective supplementation.

Dietary Interventions to Support Endogenous Veillonellaceae

Purpose: To naturally increase abundance and activity without direct supplementation.

· Consume Nitrate-Rich Vegetables: Beets, spinach, arugula, and other leafy greens provide nitrate that supports Veillonella growth and nitric oxide production.

· Include Fermentable Carbohydrates: Dietary fibers and fermentable carbohydrates promote lactate-producing bacteria, providing substrate for Veillonella.

· Maintain Oral Health: As the primary reservoir of Veillonellaceae, oral health directly impacts the abundance and diversity of these bacteria.

· Consider Probiotic Combinations: Lactobacillus and Bifidobacterium species produce lactate that can support Veillonella growth.

Strategies to Prevent Pathogenic Translocation

Purpose: To reduce risk of Veillonella contribution to systemic disease.

· Oral Health Maintenance: Preventing periodontal disease reduces the reservoir of Veillonella and other oral bacteria that can translocate to the gut.

· Gut Barrier Support: Maintaining intestinal barrier integrity through dietary fiber, butyrate production, and avoidance of barrier-disrupting agents may reduce translocation risk.

· Targeted Decolonization: In high-risk patients (e.g., those with advanced liver disease), strategies to reduce oral Veillonella load may be beneficial.

---

6. In-Depth Mechanistic Profile and Clinical Significance

The Lactate-Feeding Lifestyle: A Unique Ecological Strategy

Veillonellaceae occupy a distinctive metabolic niche defined by their inability to ferment carbohydrates directly and their absolute dependence on lactate or other organic acids. This lifestyle shapes their ecological relationships and clinical significance.

· Metabolic Cross-Feeding: Veillonella species form metabolic consortia with lactate-producing bacteria, including streptococci, lactobacilli, and other Firmicutes. This relationship is mutualistic: lactate producers benefit from removal of lactate, which can be toxic at high concentrations, while Veillonella gains its energy source.

· Oral Biofilm Ecology: In dental plaque, Veillonella adheres to streptococci and other early colonizers, establishing the structural framework for multispecies biofilms. This bridging function enables the development of complex communities that include later colonizers.

· Ecological Succession: As plaque matures, Veillonella populations shift in response to changes in lactate availability and the arrival of other species. Their presence facilitates the establishment of periodontopathogens, contributing to disease progression.

The Oral–Gut Axis: A Pathway to Systemic Disease

The recognition that oral bacteria can translocate to the gut and contribute to systemic disease represents a paradigm shift in understanding the microbiome's role in health and disease.

· Translocation Mechanisms: Oral bacteria reach the gut through swallowing of saliva. In healthy individuals, most are eliminated by gastric acid and the competitive gut microbiota. In disease states, barrier dysfunction and microbial community alterations enable ectopic colonization.

· Risk Factors for Translocation: Factors that promote oral–gut translocation include:

· Periodontal disease, increasing oral bacterial load

· Reduced gastric acidity (e.g., proton pump inhibitor use)

· Gut barrier impairment (e.g., chronic liver disease, inflammatory bowel disease)

· Altered gut microbiome composition

· Disease Associations: Oral–gut translocation has been implicated in:

· Advanced chronic liver disease

· Inflammatory bowel disease

· Colorectal cancer

· Rheumatoid arthritis

· Type 1 diabetes

· Hypertension

The Collagenase Connection: A Mechanistic Link to Liver Disease

The identification of prtC-encoded collagenase as a key virulence factor in translocating Veillonella has provided a mechanistic explanation for their role in ACLD.

· Enzyme Function: PrtC is a collagenase-like proteinase that degrades type I collagen, the primary structural component of the intestinal basement membrane and extracellular matrix.

· Barrier Disruption: Collagenase activity weakens the intestinal barrier, increasing permeability to bacteria and bacterial products, including lipopolysaccharide (LPS) and other inflammatory molecules.

· Portal Vein Translocation: Bacterial products enter the portal circulation and reach the liver, where they activate hepatic stellate cells and promote fibrosis through Toll-like receptor signaling.

· Disease Progression: The resulting fibrosis impairs liver function, increases portal pressure, and further compromises gut barrier function, creating a vicious cycle of disease progression.

· Biomarker Utility: Fecal prtC abundance correlates with disease severity and distinguishes ACLD patients from healthy controls, offering a non-invasive tool for risk stratification.

The Athletic Paradox: Beneficial Lactate Removal

The role of Veillonella in athletic performance illustrates how the same metabolic capability (lactate fermentation) can be beneficial in one context and pathogenic in another.

· Lactate as a Signaling Molecule: During intense exercise, lactate levels rise in the bloodstream and in the gut. Traditionally viewed as a metabolic waste product, lactate is now recognized as a signaling molecule with diverse effects.

· Veillonella Proliferation: Post-exercise, Veillonella abundance increases, likely due to the availability of lactate substrate.

· Propionate Benefits: Propionate produced from lactate fermentation may:

· Serve as an energy substrate for the host

· Modulate immune function

· Enhance mitochondrial function

· Reduce oxidative stress

· Performance Enhancement: The 13% improvement in running time observed in Veillonella-colonized mice suggests a meaningful effect that could translate to human athletic performance.

Nitrate Metabolism: Connecting Diet, Microbiome, and Cardiovascular Health

The ability of Veillonellaceae to reduce nitrate links dietary patterns to microbial activity and host physiology.

· Dietary Sources: Leafy green vegetables, beets, and other plant foods are rich in nitrate, which is absorbed and concentrated in saliva.

· Oral Nitrate Reduction: Oral bacteria, including Veillonella, reduce nitrate to nitrite. Nitrite is swallowed and can be further reduced to nitric oxide in the acidic stomach or by other bacteria.

· Nitric Oxide Functions: Nitric oxide regulates vascular tone, inhibits platelet aggregation, modulates immune responses, and influences gastrointestinal motility.

· Cardiovascular Benefits: The nitrate-nitrite-nitric oxide pathway is associated with reduced blood pressure, improved endothelial function, and reduced cardiovascular risk.

· Amino Acid Utilization: Recent research demonstrates that nitrate enables Veillonella to utilize glutamate and aspartate in lactate-deficient environments, producing tryptophan and short-chain fatty acids. This metabolic flexibility may contribute to the health benefits associated with nitrate-rich diets.

The Microgeography of Oral–Gut Translocation

Understanding the spatial and temporal dynamics of oral–gut translocation is critical for developing effective interventions.

· Saliva as a Vector: Oral bacteria are continuously swallowed, providing a constant stream of potential colonizers to the gut.

· Gastric Barrier: The acidic stomach eliminates most swallowed bacteria, but some species, including Veillonella, can survive gastric transit, particularly when protected by food or biofilm structures.

· Small Intestinal Colonization: Surviving bacteria may establish transient or persistent populations in the small intestine, where lactate and other substrates are available.

· Large Intestinal Establishment: In the colon, Veillonella must compete with established communities and may only persist when the ecological niche is available (e.g., after antibiotic treatment or in disease states).

· Strain-Level Specificity: Not all Veillonella strains are equally capable of translocation or disease contribution. Strain-level genomic features, including the presence of prtC, determine pathogenic potential.

---

7. Dietary Strategies to Support Endogenous Veillonellaceae

Purpose: To naturally enhance Veillonellaceae abundance and beneficial activity while minimizing pathogenic potential.

Consume Nitrate-Rich Vegetables

Dietary nitrate is a key modulator of Veillonella growth and activity.

· Leafy Greens: Spinach, arugula, kale, Swiss chard, and other leafy greens are rich in nitrate.

· Root Vegetables: Beets, carrots, and radishes provide significant nitrate content.

· Cruciferous Vegetables: Broccoli, cauliflower, and cabbage contain moderate nitrate levels.

· Consumption Timing: Regular consumption, rather than acute high doses, supports sustained microbial activity.

Include Fermentable Carbohydrates

Fermentable carbohydrates promote lactate-producing bacteria, providing substrate for Veillonella.

· Whole Grains: Oats, barley, wheat, and rye provide fermentable fibers that support saccharolytic bacteria.

· Legumes: Beans, lentils, and chickpeas are rich in fermentable carbohydrates.

· Fruits and Vegetables: Diverse plant foods provide varied fermentable substrates.

Consider Lactate-Containing Fermented Foods

Some fermented foods contain lactate that may directly support Veillonella.

· Yogurt and Kefir: Fermented dairy products contain lactate from bacterial fermentation.

· Sauerkraut and Kimchi: Fermented vegetables contain lactate and may also provide live bacteria.

· Sourdough Bread: Contains lactate from the fermentation process.

Maintain Oral Health

As the primary reservoir of Veillonellaceae, oral health directly influences gut colonization.

· Regular Dental Care: Professional cleanings and good oral hygiene reduce pathogenic oral bacteria.

· Avoid Excessive Sugar: High sugar intake promotes acidogenic bacteria and may disrupt oral microbial balance.

· Consider Xylitol: Xylitol-containing products may reduce pathogenic bacteria while supporting beneficial species.

Support Gut Barrier Integrity

Maintaining the intestinal barrier may prevent pathogenic translocation of Veillonella.

· Dietary Fiber: Soluble fibers support butyrate production, which strengthens the gut barrier.

· Polyphenols: Plant polyphenols may enhance barrier function and modulate microbial communities.

· Avoid Barrier Disruptors: Excessive alcohol, non-steroidal anti-inflammatory drugs (NSAIDs), and processed foods may compromise barrier integrity.

---

8. Foods and Factors to Limit

High-Sugar Diets

Excessive sugar promotes lactate-producing bacteria and may alter the balance of oral and gut communities.

· Dental Caries: Sugar drives acidogenic bacteria, increasing caries risk and altering oral ecology.

· Microbial Imbalance: High sugar intake may promote overgrowth of lactate-producing bacteria, altering the substrate available for Veillonella.

Poor Oral Hygiene

Inadequate oral hygiene increases pathogenic bacterial load and may promote translocation.

· Periodontal Disease: Untreated periodontal disease increases the reservoir of oral bacteria capable of translocation.

· Dental Plaque Accumulation: Plaque provides a protected environment for Veillonella and other bacteria.

Proton Pump Inhibitors (PPIs)

PPIs reduce gastric acidity, potentially enhancing survival of swallowed bacteria.

· Increased Translocation Risk: Reduced gastric acid may facilitate oral–gut translocation of Veillonella and other bacteria.

· Association with Disease: PPI use is associated with increased risk of various gut infections and may contribute to dysbiosis.

Excessive Alcohol

Chronic heavy alcohol consumption disrupts the gut barrier and alters microbial communities.

· Barrier Disruption: Alcohol increases intestinal permeability, potentially facilitating translocation.

· Liver Disease: Alcohol is a major cause of chronic liver disease, which is associated with Veillonella translocation.

Unnecessary Antibiotics

Broad-spectrum antibiotics deplete beneficial bacteria and may create niches for opportunistic colonization.

· Microbiome Disruption: Antibiotics alter both oral and gut microbial communities.

· Resistance Selection: Antibiotic use drives selection of resistant strains.

---

9. Therapeutic Potential in Specific Disease States: A Summary

Periodontitis and Oral Disease

Veillonella abundance in saliva and subgingival plaque correlates with periodontal disease severity. While Veillonella may not be a primary pathogen, its role in biofilm ecology and its association with periodontopathogens position it as a potential target for diagnostic or therapeutic strategies. Reducing Veillonella abundance through improved oral hygiene may disrupt the ecological networks that support periodontitis.

Advanced Chronic Liver Disease (ACLD)

Oral–gut translocation of Veillonella contributes to ACLD pathogenesis through prtC-encoded collagenase activity. This discovery has multiple therapeutic implications:

· Fecal prtC abundance serves as a non-invasive biomarker for disease progression

· PrtC represents a potential therapeutic target for preventing disease progression

· Strategies to prevent oral–gut translocation could reduce disease burden

· Early identification of high-risk patients could enable preventive interventions

Athletic Performance Enhancement

The association between Veillonella and improved endurance positions this family as a promising candidate for sports nutrition. Veillonella atypica shows safety and functional properties that support its development as a probiotic for athletes. Clinical trials are needed to confirm performance benefits in humans and to optimize dosing and delivery.

Inflammatory Bowel Disease

Veillonella abundance is altered in IBD, and oral–gut translocation has been observed. The potential for Veillonella to degrade thiopurine drugs warrants attention in IBD patients receiving these therapies. Understanding the role of Veillonella in IBD may inform strategies to optimize treatment outcomes.

Cardiovascular Health

Through the nitrate-nitrite-nitric oxide pathway, Veillonella may contribute to cardiovascular benefits associated with nitrate-rich diets. Supporting Veillonella through dietary nitrate may be a strategy for enhancing nitric oxide production and cardiovascular health.

Rheumatoid Arthritis and Autoimmune Diseases

Oral–gut translocation of Veillonella and other oral bacteria has been implicated in multiple autoimmune conditions. Understanding the mechanisms of translocation and the factors that enable ectopic colonization may reveal new therapeutic targets for preventing or treating these diseases.

---

10. Conclusion

The family Veillonellaceae embodies the profound connections between oral and gut health, the complexity of microbial ecology, and the dual nature of host-microbe interactions. As lactate-fermenting specialists, these bacteria occupy a unique ecological niche that positions them at the center of metabolic cross-feeding networks, converting the waste products of other bacteria into short-chain fatty acids that influence host physiology across multiple organ systems.

The scientific discoveries of 2024 through 2026 have revealed both the beneficial and pathogenic faces of this family. The demonstration that Veillonella atypica can enhance athletic performance by metabolizing lactate to propionate opens new frontiers in sports nutrition and the gut-muscle axis. Simultaneously, the elucidation of Veillonella's role in oral–gut translocation and the pathogenesis of advanced chronic liver disease, driven by the prtC collagenase gene, provides mechanistic insights into a major global health burden and identifies new diagnostic and therapeutic opportunities.

These seemingly contradictory findings underscore a fundamental principle of microbiome science: the same bacterial family can be beneficial or harmful depending on context, including the host environment, the presence of virulence factors, and the integrity of host barriers. The Veillonellaceae, with their lactate-feeding lifestyle and their position at the intersection of oral and gut communities, serve as a model for understanding how bacteria navigate different host environments and how their activities shift from commensal to pathogenic.

As research continues to unravel the complexities of this family, Veillonellaceae are poised to become important players in personalized medicine, serving as biomarkers for disease risk, targets for therapeutic intervention, and tools for enhancing human performance. The challenge ahead lies in harnessing their beneficial potential while mitigating their pathogenic risks, developing strategies that preserve the integrity of the oral–gut axis and maintain the delicate balance between host and microbe.

---

11. Reference Books for In-Depth Study

· The Oral Microbiome: Methods and Protocols by Guy R. Adami

· The Gut-Liver Axis: Dietary and Therapeutic Interventions by Emanuele Cacci and John McLaughlin

· Periodontal Disease and Systemic Health by Kenneth A. Krebs and Margherita Fontana

· Probiotics and Prebiotics in Human Nutrition and Health by Venketeshwer Rao and Leticia Rao

· Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications by Joel Faintuch and Salomao Faintuch

· Current research literature in journals including Nature Microbiology, Gut, The ISME Journal, Applied and Environmental Microbiology, and Journal of Clinical Periodontology

---

12. Further Study: Microbes and Interventions That Might Interest You Due to Similar Therapeutic Properties

Lactobacillus Species (Lactobacillaceae)

Phylum: Bacillota

Similarities: Lactobacillus species are major lactate producers, forming metabolic consortia with Veillonella. The two groups are linked through cross-feeding, with Lactobacillus providing lactate that Veillonella converts to propionate. Together, they represent a classic example of microbial metabolic cooperation with implications for oral and gut health.

Streptococcus salivarius (Streptococcaceae)

Phylum: Bacillota

Similarities: S. salivarius is a prominent early colonizer of the oral cavity and a major lactate producer. It forms metabolic partnerships with Veillonella in dental plaque and has been studied as a probiotic for oral health and halitosis. The Streptococcus-Veillonella interaction is a model system for understanding microbial ecology in the oral cavity.

Nitrate-Rich Vegetables (Beets, Spinach)

Intervention: Dietary prebiotic

Similarities: Dietary nitrate supports Veillonella growth and activity through nitrate respiration. The health benefits of nitrate-rich vegetables, including blood pressure reduction and improved exercise performance, may be partially mediated through Veillonella and other nitrate-reducing bacteria.

Propionate-Producing Bacteria (e.g., Akkermansia muciniphila)

Phylum: Verrucomicrobiota

Similarities: Like Veillonella, Akkermansia muciniphila produces propionate and has been associated with metabolic health benefits. Both groups are being investigated as next-generation probiotics for metabolic disorders, though they occupy different ecological niches (mucus degradation vs. lactate fermentation).

Porphyromonas gingivalis and Red Complex Bacteria

Phylum: Bacteroidota

Similarities: The "red complex" bacteria (P. gingivalis, Tannerella forsythia, Treponema denticola) are key periodontopathogens that associate with Veillonella in dental plaque. Understanding the ecological relationships between Veillonella and these pathogens is essential for developing effective periodontal therapies.

Phage Therapy for Oral Biofilms

Intervention: Bacteriophages

Similarities: As Veillonella are key components of oral biofilms, phage therapy targeting Veillonella could potentially disrupt biofilms and reduce periodontitis risk. This approach parallels phage therapy development for other biofilm-associated infections.

---

Disclaimer

The family Veillonellaceae encompasses diverse bacterial species and strains with complex, context-dependent effects on human health. While certain strains show promise as probiotics for athletic performance, others may contribute to disease pathogenesis in susceptible individuals, particularly those with advanced chronic liver disease. Live biotherapeutic products based on Veillonellaceae are investigational and not currently approved for medical use. Dietary strategies to support these bacteria should be implemented as part of overall healthy eating patterns. Individuals with chronic liver disease or other conditions associated with oral–gut translocation should consult healthcare providers before making significant dietary changes. This information is for educational purposes only and is not a substitute for professional medical advice.